Abstract:Ebola virus (EBOV) entry into host cells comprises stepwise and extensive interactions of the sole viral surface glycoprotein (GP) with multiple host factors. During the intricate process, following virus uptake and trafficking to late endosomal/lysosomal compartments, GP is proteolytically processed to cleaved GP (GPCL) by the endosomal proteases cathepsin B and L, unmasking GP's receptor-binding site. Engagement of GPCL with the universal filoviral intracellular receptor Niemann-Pick C1 (NPC1) eventually culminates in fusion between viral and cellular membranes, cytoplasmic escape of the viral nucleocapsid, and subsequent infection. Mechanistic delineation of the indispensable GPCL-NPC1-binding step has been severely hampered by the unavailability of a robust cell-based assay assessing interaction of GPCL with full-length endosomal NPC1. Here, we describe a novel in situ assay to monitor GPCL-NPC1 engagement in intact, infected cells. Visualization of the subcellular localization of binding complexes is based on the principle of DNA-assisted, antibody-mediated proximity ligation. Virus-receptor binding monitored by proximity ligation was contingent on GP's proteolytic cleavage and was sensitive to perturbations in the GPCL-NPC1 interface. Our assay also specifically decoupled detection of virus-receptor binding from steps post-receptor binding, such as membrane fusion and infection. Testing of multiple FDA-approved small-molecule inhibitors revealed that drug treatments inhibited virus entry and GPCL-NPC1 recognition by distinctive mechanisms. Together, here we present a newly established proximity ligation assay, which will allow us to dissect cellular and viral requirements for filovirus-receptor binding and to delineate the mechanisms of action of inhibitors on filovirus entry in a cell-based system.IMPORTANCE Ebola virus causes episodic but increasingly frequent outbreaks of severe disease in Middle Africa, as shown by the recently overcome second largest outbreak on record in the Democratic Republic of Congo. Despite considerable effort, FDA-approved anti-filoviral therapeutics or targeted interventions are not available yet. Virus host-cell invasion represents an attractive target for antivirals; however, our understanding of the inhibitory mechanisms of novel therapeutics is often hampered by fragmented knowledge of the filovirus-host molecular interactions required for viral infection. To help close this critical knowledge gap, here, we report an in situ assay to monitor binding of the EBOV glycoprotein to its receptor NPC1 in intact, infected cells. We demonstrate that our in situ assay based on proximity ligation represents a powerful tool to delineate receptor-viral glycoprotein interactions. Similar assays can be utilized to examine receptor interactions of diverse viral surface proteins whose studies have been hampered until now by the lack of robust in situ assays.

Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination

The Lifecycle of the Ebola Virus in Host Cells.

Tunneling Nanotubes: The Cables for Viral Spread and Beyond

Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion

Intracellular Ebola virus nucleocapsid assembly revealed by in situ cryo-electron tomography

Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by In Situ Proximity Ligation

Intracellular Ebola Virus nucleocapsid assembly revealed by in situ cryo-electron tomography.

A role for tunneling nanotubes in virus spread

Ebola Virus Entry: From Molecular Characterization to Drug Discovery

Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics

Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway

Multiple dermal cell types support productive infection and dynamic translocation of infectious Ebola virus to the apical surface of human skin

Insight into the Ebola Virus Nucleocapsid Assembly Mechanism: Crystal Structure of Ebola Virus Nucleoprotein Core Domain at 1.8 Å Resolution.

Cell-cell contact promotes Ebola virus GP-mediated infection

Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses

Resurgence of Ebola Virus: Transmission, Pathogenesis, Prevention and Cure

Computational Models for Trapping Ebola Virus Using Engineered Bacteria

Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer

Ebola Virus Disease: Virology, Pathogenesis, Therapy, and Vaccines

Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates